The value of goods exceeds 100 billion, and a glimpse of the export situation of domestic new crown vaccine in 2021

TextPills

According to customs data, the cumulative export value of human vaccines in China in 2021 will exceed 101 billion yuan

5 domestically produced new crown vaccines exported from my country to overseas markets in 2021

On May 7, 2021, the new crown vaccine of China Sinopharm Group Beijing Institute obtained emergency use authorization from the World Health Organization, and its virus inactivated vaccine was approved for global promotion and use

In mid-October 2020, Beijing Kexing Zhongwei submitted an application to the WHO for inclusion in the emergency use list, and submitted relevant information in accordance with the requirements of the WHO for the WHO to conduct continuous evaluation of vaccine safety, efficacy and product quality

On June 22 of the same year, 4 departments including the Ministry of Commerce of China issued an announcement to list 4 vaccines that have been approved for marketing with conditions in China into the list of new crown vaccine products available for export, and expressed their support for the production of Chinese vaccines included in the list.

Source: Official website of each company, Guotai Junan Securities

In October, the new crown vaccines of five Chinese vaccine manufacturers, Sinopharm Zhongsheng, Kexing Bio, CanSino, Zhifei Bio and Kangtai Bio, were exported to overseas markets, including three types of new crown vaccines, with a total annual production capacity of more than 8 billion agent

The top five countries in the export of domestically produced new crown vaccines

From a global perspective, countries or regions with vaccine production or R&D capabilities in 2021 are mainly concentrated in regions with strong comprehensive technical strength such as Europe, America, Japan, India, and China, and countries with relatively large populations such as Indonesia, Bangladesh, and Brazil.

China's vaccine export orders continue to increase, and the products have covered more than 112 countries, regions and international organizations around the world

In 2021, the export value of the whole year will exceed 100 billion yuan.

Major powers assume that China has become the main supplier of new crown vaccines to developing countries

Since the outbreak of the new crown epidemic, General Secretary Xi has actively promoted the process of international cooperation on vaccines on many international occasions

On August 5, General Secretary Xi Jinping stated at the first meeting of the International Forum on New Crown Vaccine Cooperation that China will strive to provide 2 billion doses of vaccines to the world in 2021

As a major supplier of global public goods, China has made a positive contribution to making COVID-19 vaccines accessible and affordable in developing countries